146328-87-2

Basic information

• Product Name: 5-CYANO-2-FLUOROBENZOIC ACID
• Synonyms: 3-Carboxy-4-fluorobenzonitrile;5-CYANO-2-FLUOROBENZOIC ACID 5-;Benzoic acid,5-cyano-2-fluoro-
• CAS NO: 146328-87-2
• Molecular Formula: C₈H₄FNO₂
• Molecular Weight: 165.12
• Mol File: 146328-87-2.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 322.066 °C at 760 mmHg
• Flash Point: 148.58 °C
• Appearance: /
• Density: 1.425 g/cm³
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 2.71±0.10(Predicted)
• CAS DataBase Reference: 5-CYANO-2-FLUOROBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 5-CYANO-2-FLUOROBENZOIC ACID(146328-87-2)
• EPA Substance Registry System: 5-CYANO-2-FLUOROBENZOIC ACID(146328-87-2)

Safety Data

• Hazardous Substances Data: 146328-87-2(Hazardous Substances Data)

Usage

General Description

5-Cyano-2-fluorobenzoic acid is a chemical compound with the molecular formula C8H4FNO2. It is a derivative of benzoic acid and contains a cyano group and a fluorine atom. The compound is commonly used in the pharmaceutical industry as an intermediate in the synthesis of various drugs and active pharmaceutical ingredients. It has also been studied for its potential antimicrobial and anticancer properties. The chemical is a white to off-white powder and is sparingly soluble in water. Its precise applications and uses are diverse and depend on the specific chemical properties and reactivity of the compound.

Upstream product

• 124-38-9 carbon dioxide 
• 79630-23-2 3-bromo-4-fluorobenzonitrile 
• 93777-26-5 5-bromo-2-fluorobenzaldehyde 
• 146137-79-3 4-fluoro-3-formylbenzonitrile 
• 337362-21-7 methyl 5-cyano-2-fluorobenzoate 
• 7758-19-2 sodium chlorite 
• 10049-21-5 sodium dihydrogenphosphate 
• 1194-02-1 4-fluorobenzonitrile 

Downstream Products

• 335256-12-7 5-cyano-2-fluorobenzoyl chloride 
• 247567-01-7 2-(tert-Butoxyamino)-5-nitro-N-(1,3-benzodioxol-5-ylmethyl)benzamide 
• 247568-56-5 (R)-5-cyano-2-(2-hydroxy-1-methylethylamino)-N-(1,3-benzodioxol-5-ylmethyl)benzamide 
• 247566-86-5 (R)-2-(2-Hydroxy-1-methylethylamino)-5-nitro-N-(1,3-benzodioxol-5-ylmethyl)benzamide 
• 247566-87-6 5-Nitro-N-(1,3-benzodioxol-5-ylmethyl)-2-(2-thiazolylamino)benzamide 
• 247566-83-2 (S)-2-(1-carboxyethylamino)-5-nitro-N-(1,3-benzodioxol-5-ylmethyl)benzamide 
• 247566-85-4 2-(2-Hydroxy-1,1-dimethylethylamino)-5-nitro-N-(1,3-benzodioxol-5-ylmethyl)benzamide 
• 247568-38-3 2-[2-Chloro-1-(chloromethyl)ethylamino]-5-nitro-N-(1,3-benzodioxol-5-ylmethyl)benzamide 
• 247566-81-0 (S)-2-[1-(chloromethyl)propylamino]-5-nitro-N-(1,3-benzodioxol-5-ylmethyl)benzamide 
• 247566-91-2 (R)-2-[1-(Methoxycarbonyl)ethylamino]-5-nitro-N-(1,3-benzodioxol-5-ylmethyl)benzamide 
• 247567-05-1 (S)-2-[1-(Hydroxymethyl)-2-methylpropylamino]-5-nitro-N-(1,3-benzodioxol-5-ylmethyl)benzamide 
• 247567-28-8 (R)-5-carbamoyl-2-(2-hydroxy-1-methylethylamino)-N-(1,3-benzodioxol-5-ylmethyl)benzamide 
• 247568-37-2 2-[2-hydroxy-1-(hydroxymethyl)ethylamino]-5-nitro-N-(1,3-benzodioxol-5-ylmethyl)benzamide 
• 247566-89-8 (R)-5-Nitro-2-(tetrahydro-3-furanylamino)-N-(1,3-benzodioxol-5-ylmethyl)benzamide 

Relevant articles and documents

Milled Dry Ice as a C1 Source for the Carboxylation of Aryl Halides

The use of carbon dioxide as a C1 chemical feedstock remains an active field of research. Here we showcase the use of milled dry ice as a method to promote the availability of CO 2in a reaction solution, permitting practical synthesis of arylcarboxylic acids. Notably, the use of milled dry ice produces marked increases in yields relative to those obtained with gaseous CO 2, as previously reported in the literature.

SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS

The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthr

NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS

The present application relates to cannabinoid receptor ligands of formula (I) wherein X1, A1, Rx, R2, R3, R4, and z are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions.